Sort   by:  
 Page size 
0
UnknownSmallpox vaccine safety is dependent on T cells and not B cells.
Not available
S-EPMC3068024 | biostudies-literature
0
UnknownTissue memory B cell repertoire analysis after ALVAC/AIDSVAX B/E gp120 immunization of rhesus macaques.
Not available
S-EPMC5135278 | biostudies-literature
0
UnknownIDLV-HIV-1 Env vaccination in non-human primates induces affinity maturation of antigen-specific memory B cells.
Not available
S-EPMC6125466 | biostudies-literature
0
UnknownPotent and broad HIV-neutralizing antibodies in memory B cells and plasma.
Not available
S-EPMC5905719 | biostudies-literature
0
UnknownInitiation of immune tolerance-controlled HIV gp41 neutralizing B cell lineages.
Not available
S-EPMC5006673 | biostudies-literature
0
UnknownComparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost.
Not available
S-EPMC4474309 | biostudies-literature
0
UnknownThe transcription factor CREB1 is a mechanistic driver of immunogenicity and reduced HIV-1 acquisition following ALVAC vaccination.
Not available
S-EPMC8525330 | biostudies-literature
0
UnknownImmunogenicity of NYVAC Prime-Protein Boost Human Immunodeficiency Virus Type 1 Envelope Vaccination and Simian-Human Immunodeficiency Virus Challenge of Nonhuman Primates.
Not available
S-EPMC5874432 | biostudies-literature
0
UnknownOvercoming Steric Restrictions of VRC01 HIV-1 Neutralizing Antibodies through Immunization.
Not available
S-EPMC6936959 | biostudies-literature
0
UnknownBoosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial.
Not available
S-EPMC5342261 | biostudies-literature
Sort   by:  
 Page size